Related references
Note: Only part of the references are listed.mTOR Mediates Wnt-Induced Epidermal Stem Cell Exhaustion and Aging
Rogerio M. Castilho et al.
CELL STEM CELL (2009)
Tuberous sclerosis complex, implication from a rare genetic disease to common cancer treatment
Ken Inoki et al.
HUMAN MOLECULAR GENETICS (2009)
Molecular mechanisms of mTOR-mediated translational control
Xiaoju Max Ma et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Practical recommendations for the early use of m-TOR inhibitors (sirolimus) in renal transplantation
Josep M. Campistol et al.
TRANSPLANT INTERNATIONAL (2009)
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
Jeffrey A. Engelman
NATURE REVIEWS CANCER (2009)
Vascular permeability, vascular hyperpermeability and angiogenesis
Janice A. Nagy et al.
ANGIOGENESIS (2008)
Chemoprevention and treatment of experimental Cowden's disease by mTOR inhibition with rapamycin
Cristiane H. Squarize et al.
CANCER RESEARCH (2008)
Cancer as an overhealing wound:: an old hypothesis revisited
Matthias Schaefer et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
The role of PTEN signaling perturbations in cancer and in targeted therapy
M. Keniry et al.
ONCOGENE (2008)
Fifteen Years of Clinical Studies and Clinical Practice in Renal Transplantation: Reviewing Outcomes With De Novo Use of Sirolimus in Combination With Cyclosporine
B.D. Kahan
TRANSPLANTATION PROCEEDINGS (2008)
Growth factors and cytokines in wound healing
Stephan Barrientos et al.
WOUND REPAIR AND REGENERATION (2008)
Phosphatase and tensin homologue deleted on chromosome ten (PTEN) as a molecular target in lung epithelial wound repair
J-P Lai et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Requirement of Rac1 distinguishes follicular from interfollicular epithelial stem cells
R. M. Castilho et al.
ONCOGENE (2007)
Risk factors for impaired wound healing in sirolimus-treated renal transplant recipients
Richard J. Knight et al.
CLINICAL TRANSPLANTATION (2007)
The tuberous sclerosis complex
Peter B. Crino et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
mTOR and cancer: insights into a complex relationship
David M. Sabatini
NATURE REVIEWS CANCER (2006)
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Jeffrey A. Engelman et al.
NATURE REVIEWS GENETICS (2006)
Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis
M Cully et al.
NATURE REVIEWS CANCER (2006)
Update on tissue-engineered biological dressings
M. Ehrenreich et al.
TISSUE ENGINEERING (2006)
A small-molecule inhibitor for phosphatase and tensin homologue deleted on chromosome 10 (PTEN)
Erika Rosivatz et al.
ACS CHEMICAL BIOLOGY (2006)
A comparative study of sirolimus tablet versus oral solution for prophylaxis of acute renal allograft rejection
TH Mathew et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Exploiting the PI3K/AKT pathway for cancer drug discovery
BT Hennessy et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Accelerated re-epithelialization in β3-integrin-deficient mice is associated with enhanced TGF-β1 signaling
LE Reynolds et al.
NATURE MEDICINE (2005)
A mouse model of cardiac rhabdomyoma generated by loss of Tsc1 in ventricular myocytes
L Meikle et al.
HUMAN MOLECULAR GENETICS (2005)
Epithelial Bmpr1a regulates differentiation and proliferation in postnatal hair follicles and is essential for tooth development
T Andl et al.
DEVELOPMENT (2004)
Phosphatases as small-molecule targets: inhibiting the endogenous inhibitors of kinases
AC Schmid et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2004)
Tumor suppressor PTEN mediates sensing of chemoattractant gradients
M Iijima et al.
CELL (2002)
Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo
M Groszer et al.
SCIENCE (2001)
Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study
BD Kahan
LANCET (2000)
Share Paper
